Page last updated: 2024-11-08

trimerazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

trimerazine: combination of above [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID162742
MeSH IDM0062598

Synonyms (6)

Synonym
54242-77-2
berlocombin
4-amino-n-(4-methyl-2-pyrimidinyl)benzenesulfonamide, mixt. with 5-((3,4,5-trimethoxyphenyl)meth yl)-2,4-pyrimidinediamine
trimerazine
DTXSID70969231
4-amino-n-(4-methylpyrimidin-2-yl)benzene-1-sulfonamide--5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4(1h,3h)-diimine (1/1)

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The results of this study failed to be of practical consequences, because the dosage applied and recommended by the producer significantly exceeded the minimum inhibition concentrations in serum and urine 3 h after administration."( [The influence of galenic and biologic factors on the bioavailability of Berlocombin].
Traeger, A; Truckenbrodt, J, 1984
)
0.27
" There are no consequences concerning the dosage of Berlocombin in bacterial infections during pregnancy."( [Studies on the pharmacokinetics of the compound preparation sulfamerazine/trimethoprim (Berlocombin-200) in pregnancy].
Müller, B; Nöschel, H; Peiker, G; Pischke, U; Schröder, S; Traeger, A, 1982
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (92.31)18.7374
1990's1 (7.69)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.56 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.69%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (15.38%)4.05%
Observational0 (0.00%)0.25%
Other10 (76.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]